Bad news.
Bankruptcy declared for the swiss company developing #temelimab for #MultipleSclerosis (phase 2 done).

What about its participation to the european Hervcov project (Covid19, Long COVID)?

And about the preclinical GNK301 for ALS ?

#HERV-W
#HERV-K

www.businesswire.com/news/home/20...

ClinicalTrials.gov

Sadly it looks like that the becessary $100 millions funding for a p3 trial including ppwMS very disabled is a Holy Grail.
Meanwhile billions are invested in #AI.
#temelimab had good results on remyelination but who cares?

The results or the ProTect-MS p2 trial:

clinicaltrials.gov/study/NCT044...

Joie d'avoir passé à côté de ma vie 😤😤

#MultipleSclerosis No Cure
#Sclérose En Plaques Incurable
#Disability worsening
#Handicap

📣 I need #Temelimab

Btw have been treated with Acyclovir and Valaciclovir, and it nothing more than tackle the shingles I had.

Test an antiretroviral? Yes I would happily test #temelimab if possible. I may also have LC symptoms.

#LongCovid

" #Temelimab - Where am I since the end of the study?
TL;DR I'm doing better."

@Anthony

Temelimab - Où en suis-je depuis la fin de l'étude ? TL;DR Je vais mieux.

#CovidLong

" #Temelimab - Où en suis-je depuis la fin de l'étude ?
TL;DR Je vais mieux."

@Anthony

Molecular dissection of HERV-W dependent microglial- and astroglial cell polarization The endogenous retrovirus type W (HERV-W) is a human-specific entity, which was initially discovered in multiple sclerosis (MS) patient derived cells.…

Toujours pas de traitement curatif pour la #SEP 🥺 et pas de réparation des cellules nerveuses endommagées par la démyélinisation. Sauf que la piste évoquée dans cet article risque de s'arrêter faute de financement. 😡

#temelimab must be tested, p3 trials needed #MultipleSclerosis
#HERV-W
#Myelin

Swiss biotech company GeNeuro secures €5M to accelerate post-COVID treatment trials

#LongCovid #HERV reactivatie

Het Zwitserse biotechbedrijf GeNeuro haalt 5 miljoen euro binnen om de onderzoeken naar #Temelimab behandeling na COVID-19 te versnellen

siliconcanals.com/news/startup...

Long Covid: Komme ich da je wieder raus? - Kopf voran - SRF Fatigue, Kurzatmigkeit, kognitive Einschränkungen: Unzählige Menschen weltweit leiden an Long Covid, auch in der Schweiz. «Wen es trifft, den trifft es hart und unvorbereitet», sagt die Basler Neu...

Spannende Podcast-Folge zum Thema #PostCovid und der #Temelimab Studie von der @unibasel.bsky.social

Nur 39 von 200 Betroffenen konnten an der #Studie teilnehmen, weil das Kriterium ein positiver „HERV-W-Env-Protein“ Bluttest ist.

Die Studie läuft bis Mai 2024.

www.srf.ch/audio/kopf-v...